An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).
Simon J Adamson, Frances J Kay-Lambkin, Amanda L Baker...
https://pubmed.ncbi.nlm.nih.gov/20347232Actively Recruiting
Led by Alba González-Roz, PhD · Updated on 2025-03-30
120
Participants Needed
2
Research Sites
N/A
Total Duration
A
Alba González-Roz, PhD
Lead Sponsor
D
Delegación del Gobierno para el Plan Nacional sobre Drogas
Collaborating Sponsor
Researchers are evaluating an App-based intervention called CANQUIT designed to help young adults reduce or quit regular cannabis use. This study aims to measure the effectiveness and cost-efficiency of this digital program at short-term (1 month) and long-term (3 and 6 months) follow-ups using 120 participants aged 18 to 30 years. The goal is to provide evidence that can guide policies to reduce the negative physical and mental health impacts of cannabis use in young adults in Spain. The CANQUIT program is a 4-week digital cognitive-behavioral therapy (CBT)-based intervention, available on both iOS and Android. Participants will be randomly assigned to either the experimental group, which receives the app-assisted CBT intervention including seven weekly modules covering psychoeducation, emotional regulation, behavioral activation, and relapse prevention, or to the control group, which receives an app-assisted self-help guide with cannabis-related information. Both groups will track cannabis use and complete follow-up assessments through the app. Participants will engage in daily self-reporting of cannabis consumption and complete follow-ups at 1, 3, and 6 months after starting the program. The study will assess cannabis abstinence, reduction, and acceptability of the intervention, as well as changes in substance use, cannabis-related problems, and emotional disorder risks. The app includes gamification and social support features to encourage adherence, and all progress is monitored remotely through the digital platform.
CONDITIONS
A Mobile App to Reduce and/or Quit Cannabis Use
You may qualify if you...
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Duration - 4 weeks
Participants engage in a 4-week digital intervention aimed at reducing or quitting cannabis use. The experimental group completes seven weekly modules including psychoeducation, emotional regulation, behavioral activation, and relapse prevention. The control group receives a self-help guide on cannabis use.
Weekly app-based activities and daily self-reporting
Duration - 6 months
Participants complete follow-up assessments at 1 month, 3 months, and 6 months after treatment to evaluate cannabis use and related outcomes.
3 follow-up assessments via app (1-month, 3-months, and 6-months)
Total: 2 locations
1
Faculty of Psychology, University of Oviedo
Oviedo, Principality of Asturias, Spain, 33003
Actively Recruiting
2
University of Oviedo
Oviedo, Principality of Asturias, Spain, 33003
Active, Not Recruiting
A
Alba González-Roz, PhD, Assistant Professor
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Simon J Adamson, Frances J Kay-Lambkin, Amanda L Baker...
https://pubmed.ncbi.nlm.nih.gov/20347232C C Attkisson, R Zwick
https://pubmed.ncbi.nlm.nih.gov/10259963